
Publication
Generative AI: A global guide to key IP considerations
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Royaume-Uni | Publication | mai 2025
On May 19, 2025, the Regulator launched a new support service which it says will “unlock” pensions industry innovation with the aim of boosting saver outcomes.
In its press release the Regulator explains that the service aims to reduce “unnecessary regulatory barriers” to pensions innovation by enabling early, transparent discussions with pensions innovators.
Two areas of particular focus will be administration and member experience (particularly in the decumulation phase).
The new support service will offer:
The Regulator has provided a link for access to the service which includes the various resources and information on upcoming events.
One of the areas in which the Regulator is particularly keen to encourage innovation is decumulation options. Its Interim Director of Policy and Public Affairs, Patrick Coyne, made a speech at the launch of a report from the Pensions Policy Institute (commissioned by the Regulator) on decumulation and value for money.
Mr Coyne suggested that savers require "a sat nav for retirement", and the Regulator’s innovation hub aims to facilitate and test a range of services with the market, including those relating to decumulation.
New decumulation duties on trustees are due to be enacted in the forthcoming Pension Schemes Bill. These are likely to require trustees to provide decumulation services themselves or offer access to such services from other providers.
Publication
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Publication
L’Union Européenne l’avait annoncé , le législateur français l’a fait : le 20 février 2025, l'Assemblée Nationale a adopté définitivement la proposition de loi restreignant la fabrication et la vente de produits contenant des PFAS2, que l’on surnomme les « polluants éternels ».
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025